Facebook
Twitter
LinkedIn
Forward
A Message from the AAAAI
As the COVID-19 pandemic continues, the AAAAI remains committed to providing you with resources that will help you navigate this difficult period. Our comprehensive set of resources includes the latest information on virus variants, talking to your patients about the COVID-19 vaccines, vaccine reactions, and more.
Rochelle P. Walensky, MD, MPH, Director of the Centers for Disease Control and Prevention (CDC)
Rochelle P. Walensky, MD, MPH, Director of the CDC, provided a brief virtual presentation at the 2023 AAAAI Annual Meeting. Her focus was the specialty and COVID-19. Watch the video.
Guidance from the ADT Interest Section for Performing Pulmonary Office Procedures During the Pandemic
A work group report from the AAAAI's Asthma Diagnosis and Treatment (ADT) Interest Section on pulmonary office procedures is now available from JACI: In Practice. This work group report has diligently reviewed all aspects of office, community and patient considerations in approaching such procedures. Read the report here.
If you are an AAAAI member and have any specific questions regarding the treatment of patients or management of your practice, please contact us at practicematters@aaaai.org. Any patients with medical questions are advised to consult their own physician provider.
Read all messages from the AAAAI COVID-19 Response Task Force
COVID-19 Vaccines and Treatments
Check this section regularly for new developments related to vaccines and treatments for COVID-19. With studies showing that patients trust their personal physicians, allergists are in a position to discuss the risks and benefits of getting vaccinated with their patients, especially considering the unique expertise of the allergist in evaluating allergic reactions to vaccines, as well as in recognizing and treating anaphylaxis.
Summaries of Key Topics
Talking to Your Patients About the COVID-19 Vaccine
Comprehensive Resource Document on Vaccines from the AAAAI’s Advocacy partner, Hart Health Strategies
Monoclonal Antibodies and Other Treatments
Resources for A/I Clinicians
 |  |  |
 |  |  |
COVID-19 Information in AAAAI Resources
AAAAI Journals
COVID-19 the Theme for the April 2023 JACI
Ask the AAAAI about COVID-19
The AAAAI invites members to send your COVID-19 questions to practicematters@aaaai.org. Questions and responses that might be helpful for a wider audience are provided in the links below. Any patients with medical questions are advised to consult their own physician provider.
Disclaimer: The AAAAI COVID-19 Response Task Force answers questions from medical professionals to provide general information for medical professionals to consider in applying their own independent clinical judgement, and the AAAAI will not be liable for any circumstances arising from a medical professional’s use or reliance upon this information. Provision of this information does not give rise to a physician-patient relationship. Any patients with medical questions are advised to consult their own physician provider.
Advocacy Updates
The Department of Health and Human Services (HHS) ended the Public Health Emergency (PHE) for COVID-19, declared under Section 319 of the Public Health Service (PHS) Act, on May 11, 2023. Review this Hart Health Strategies, Inc. summary of key excerpts of federal agency policy changes, including on telehealth and remote services, physician supervision, and other relevant policies, due to its end.